EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Astrocyte Reactivity by Mdivi-1 After Status Epilepticus in Rats Exacerbates Microglia-Mediated Neuroinflammation and Impairs Limbic–Cortical Glucose Metabolism

Francisca Gómez-Oliver iD, Rubén Fernández de la Rosa, Mirjam Brackhan iD, Pablo Bascuñana iD, Miguel Ángel Pozo iD, Luis García-García iD

Biomolecules · 27.08.2025 · 15 (9) · 1242

DOI: 10.3390/biom15091242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 27.08.2025. Verfasst von Francisca Gómez-Oliver und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Astrocytes, Status Epilepticus, Glucose, Microglia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Spanish Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lithium–pilocarpine rat model of status epilepticus (SE) is a well-established paradigm for studying epileptogenesis. Astrocyte reactivity has been implicated in modulating seizure susceptibility and neuroinflammation, yet its functional role in early epileptogenesis remains unclear. Herein, we evaluated the effects of Mdivi-1, a pharmacological inhibitor of mitochondrial fission protein Drp1, for its ability to modulate astrocytic mitochondrial dynamics and for its reported preventive neuroprotective properties. Mdivi-1 was administered shortly after SE onset, and we assessed brain glucose metabolism using [18F]FDG PET, alongside histological markers of neurodegeneration, astrocyte reactivity, and microglial activation, at 3 days post-SE. As expected, SE induced widespread brain hypometabolism measured by a VOI analysis, hippocampal neurodegeneration, and glial activation. Post-SE Mdivi-1 administration reduced hippocampal astrogliosis but neither conferred neuroprotection nor rescued glucose metabolism. On the contrary, Mdivi-1 exacerbated limbic–cortical hypometabolism when evaluated by SPM and normalized to whole brain tracer uptake and microglia-mediated neuroinflammation. These findings challenge the assumption that early astrocyte inhibition confers neuroprotection. Furthermore, early suppression of astrocyte reactivity after the damage has occurred may shift the neuroinflammatory response toward maladaptive microglial activation. Thus, while Mdivi-1 holds promise as a preventive neuroprotective agent, its use post-SE may have unintended adverse effects on the brain’s response to SE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesStatus EpilepticusGlucoseMicrogliaQuinazolinonesNeuroinflammatory DiseasesAnimalsRatsMaleHippocampusDisease Models, AnimalPilocarpineDynaminsPositron-Emission Tomography

Stichwörter der Autor:innen

2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG)Mdivi-1astrocytehypometabolismlithium–pilocarpine modelmicroglianeuroinflammationpositron emission tomography (PET)status epilepticus

Substanzen

GlucoseQuinazolinones3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinonePilocarpineDynamins

Autor:innen und Institutionen

  • Unidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Departamento de Farmacología, Farmacognosia y Botánica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos, 28040 Madrid, Spain.
  • ICTS Bioimagen Complutense (BIOIMAC), Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Departamento de Fisiología, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.

ORCID-Profile: Francisca Gómez-Oliver, Mirjam Brackhan, Pablo Bascuñana, Miguel Ángel Pozo, Luis García-García

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Instituto de Salud Carlos III
  • Spanish Ministerio de Ciencia e Innovación
  • Spanish Health Institute Carlos III

Zitieren

APA

Gómez-Oliver, F., Fernández de la Rosa, R., Brackhan, M., Bascuñana, P., Pozo, M. Á., & García-García, L. (2025). Inhibition of Astrocyte Reactivity by Mdivi-1 After Status Epilepticus in Rats Exacerbates Microglia-Mediated Neuroinflammation and Impairs Limbic–Cortical Glucose Metabolism. Biomolecules, 15(9), 1242. https://doi.org/10.3390/biom15091242

Vancouver

Gómez-Oliver F, Fernández de la Rosa R, Brackhan M, Bascuñana P, Pozo MÁ, García-García L. Inhibition of Astrocyte Reactivity by Mdivi-1 After Status Epilepticus in Rats Exacerbates Microglia-Mediated Neuroinflammation and Impairs Limbic–Cortical Glucose Metabolism. Biomolecules. 2025;15(9):1242. doi:10.3390/biom15091242

BibTeX
@article{GmezOliver2025,
  author = {Gómez-Oliver, Francisca and Fernández de la Rosa, Rubén and Brackhan, Mirjam and Bascuñana, Pablo and Pozo, Miguel Ángel and García-García, Luis},
  title = {Inhibition of Astrocyte Reactivity by Mdivi-1 After Status Epilepticus in Rats Exacerbates Microglia-Mediated Neuroinflammation and Impairs Limbic–Cortical Glucose Metabolism},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {1242},
  doi = {10.3390/biom15091242}
}
Kostenlos starten →